本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BioAge Labs Inc.

9.38
-0.1000-1.05%
盤前9.390.0100+0.11%04:00 EDT
成交量:66.16萬
成交額:618.56萬
市值:4.31億
市盈率:-3.96
高:9.65
開:9.57
低:9.16
收:9.48
52周最高:25.96
52周最低:4.42
股本:4,589.69萬
流通股本:3,757.56萬
量比:1.18
換手率:1.76%
股息:- -
股息率:- -
每股收益(TTM):-2.3710
每股收益(LYR):-2.2432
淨資產收益率:-28.21%
總資產收益率:-18.47%
市淨率:1.15
市盈率(LYR):-4.18

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/12

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/08

重要事件披露

Form 8-K - Current report
2026/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/28

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/24

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/24

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/24

重要事件披露

Form 8-K - Current report
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

重要事件披露

Form 8-K - Current report
2026/01/20

重要事件披露

Form 8-K - Current report
2026/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities